Aortic arch interruption

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2299Q25.4
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Interrupted aortic arch (IAA), also known as aortic arch interruption, is a rare congenital heart defect in which there is a complete discontinuity (gap) between two segments of the aortic arch. This means that blood cannot flow normally from the heart to the lower body through the aorta. The condition is classified into three types based on the location of the interruption: Type A (interruption distal to the left subclavian artery), Type B (interruption between the left common carotid and left subclavian arteries, the most common form), and Type C (interruption between the innominate and left common carotid arteries, the rarest form). IAA is frequently associated with other cardiac anomalies, most notably a ventricular septal defect (VSD) and patent ductus arteriosus (PDA). The PDA is critical for survival in the neonatal period, as it provides the only pathway for blood to reach the lower body. Newborns with interrupted aortic arch typically present within the first days of life with signs of cardiovascular collapse as the ductus arteriosus begins to close. Symptoms include severe respiratory distress, poor feeding, weak or absent pulses in the lower extremities, metabolic acidosis, and signs of shock. Without treatment, the condition is fatal. Type B interruption is strongly associated with 22q11.2 deletion syndrome (DiGeorge syndrome), which may include additional features such as immune deficiency, hypocalcemia, and characteristic facial features. Immediate management involves administration of prostaglandin E1 (PGE1) to maintain ductal patency and stabilize the infant. Definitive treatment requires open-heart surgery, typically performed in the neonatal period, to reconstruct the aortic arch and repair associated cardiac defects such as VSD. Surgical outcomes have improved significantly over recent decades, and many patients survive into adulthood, though long-term follow-up is essential to monitor for complications such as re-coarctation, left ventricular outflow tract obstruction, and aortic valve abnormalities. Genetic counseling is recommended, particularly when 22q11.2 deletion is identified.

Clinical phenotype terms— hover any for plain English:

Left ventricular outflow tract obstructionHP:0032092Absent pulseHP:0032554Blood pressure substantially higher in arms than legsHP:0020142Postexertional symptom exacerbationHP:0030973ShockHP:0031273Systolic heart murmurHP:0031664
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Aortic arch interruption.

View clinical trials →

No actively recruiting trials found for Aortic arch interruption at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Aortic arch interruption community →

Specialists

3 foundView all specialists →
DM
Dean B. Andropoulos, M.D.
HOUSTON, TX
Specialist
PI on 1 active trial
GA
Gabriel Altit
Specialist
PI on 1 active trial20 Aortic arch interruption publications
YM
Yifei Wang, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aortic arch interruption.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aortic arch interruptionForum →

No community posts yet. Be the first to share your experience with Aortic arch interruption.

Start the conversation →

Latest news about Aortic arch interruption

No recent news articles for Aortic arch interruption.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aortic arch interruption

What is Aortic arch interruption?

Interrupted aortic arch (IAA), also known as aortic arch interruption, is a rare congenital heart defect in which there is a complete discontinuity (gap) between two segments of the aortic arch. This means that blood cannot flow normally from the heart to the lower body through the aorta. The condition is classified into three types based on the location of the interruption: Type A (interruption distal to the left subclavian artery), Type B (interruption between the left common carotid and left subclavian arteries, the most common form), and Type C (interruption between the innominate and left

At what age does Aortic arch interruption typically begin?

Typical onset of Aortic arch interruption is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Aortic arch interruption?

3 specialists and care centers treating Aortic arch interruption are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.